Dopaminergic medication normalizes aberrant cognitive control circuit signalling in Parkinson’s disease is a research paper published in Brain (2022). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P50 AG047366
National Institutes of Health
Grant: P30 AG066515
National Institutes of Health
Grant: P50 NS062684
National Institutes of Health
Grant: NS08608505
National Institutes of Health
Grant: MH121069
NINDS NIH HHS
Grant: R01 NS086085
NINDS NIH HHS
Grant: RF1 NS086085
NIMH NIH HHS
Grant: R01 MH121069
National Institutes of Health
Grant: 5P50AG047366-03
Stanford Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P50NS062684-01A1
Pacific Northwest Udall Center
National Institutes of Health
Grant: 5P30AG066515-03
Stanford Alzheimer's Disease Research Center
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals